Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome

Clavé, P. ; Acalovschi, M. ; Triantafillidis, J. K. ; Uspensky, Y. P. ; Kalayci, C. ; Shee, V. ; Tack, J.

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (4), p.432-442 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível